Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development
Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development
Dutch B2B ingredients company Vivici BV has partnered with biotech company Ginkgo Bioworks Holdings Inc (NYSE:DNA) to develop and commercialize
https://www.benzinga.com/markets/equities/23/11/35954482/dutch-ingredients-firm-vivici-partners-with-ginkgo-bioworks-for-alternative-protein-development
Related news for (DNA)
- Breaking News: MoBot’s Latest Update as of 07/22/25 06:00 PM
- CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
- CareDx Launches Two Expanded Indications for AlloSure Testing Services
- Six Exciting Materials Stocks Heating Up the Market
- CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict